Harmony Biosciences Holdings, Inc. Board of Directors

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.

Dr. Jeffrey M. Dayno M.D.

Dr. Jeffrey M. Dayno M.D.

President, CEO & Director

Mr. Sandip S. Kapadia CPA, M.B.A.

Mr. Sandip S. Kapadia CPA, M.B.A.

Executive VP, Chief Administrative Officer & CFO

Brennan Doyle

Brennan Doyle

VP & Head of Investor Relations

Ms. Tricia Glover

Ms. Tricia Glover

Chief Compliance Officer

Mr. Christian Ulrich J.D.

Mr. Christian Ulrich J.D.

General Counsel & Corporate Secretary

Mr. David Bradshaw

Mr. David Bradshaw

Head of Technical Operations

Mr. Andrew Serafin J.D., M.B.A.

Mr. Andrew Serafin J.D., M.B.A.

Executive VP & Chief Strategy Officer

Mr. Jeffrey Dierks M.B.A.

Mr. Jeffrey Dierks M.B.A.

Executive VP & Chief Commercial Officer

Dr. Kumar Budur M.D., M.S.

Dr. Kumar Budur M.D., M.S.

Executive VP and Chief Medical & Scientific Officer

Mr. Jeffrey S. Aronin

Mr. Jeffrey S. Aronin

Founder & Non-Executive Chairman

Comments